Vitamin D and estrogen receptor polymorphisms and bone mineral changes in postpartum women

被引:18
作者
Holmberg-Marttila, D
Sievänen, H
Järvinen, TLN
Järvinen, TAH
机构
[1] Univ Tampere, Sch Med, Dept Gen Practice, FIN-33101 Tampere, Finland
[2] UKK Inst, Bone Res Grp, Tampere, Finland
[3] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland
[4] Tampere Univ Hosp, Dept Surg, Tampere, Finland
关键词
estrogen receptor; vitamin D receptor; bone mineral density; postpartum;
D O I
10.1007/PL00005836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BsmI restriction fragment length polymorphism (RFLP) of the vitamin D receptor (VDR) gene and PvuII RFLPs of the estrogen receptor (ER) gene and their relation to changes in areal bone mineral density (BMD) were examined in 43 healthy postpartum Finnish women aged 31.3 (SD 4.7) years. BMD was measured by dual energy X-ray absorptiometry at lumbar spine, right femoral neck, and dominant distal radius immediately after delivery, 1 month after resumption of menses, and 1 year thereafter. The RFLPs were represented as Bb (BsmI) and Pp (PvuII), the capital letters denoting the absence of and the small letters the presence of the restriction sites. The frequency of VDR alleles was as follows: bb (20.9%), Bb (60.5%), and BE (18.6%), and that of ER alleles was pp (39.5%), Pp (51.2%), and PP (9.3%). Altogether, BMD decreased significantly during postpartum amenorrhea at all sites [the mean bone loss ranging from -1.2 (SD 3.6)% at the distal radius to -3.7 (2.9)% at the femoral neck], and increased after resumption of menses [the 1-year follow-up BMD values ranging from -1.0 (2.4)% at the femoral neck to +3.3 (4.0)% at the lumbar spine as compared with baseline]. No obvious genotype-related differences were found between these changes. These results suggest that the BsmI and PvuII polymorphisms may not have substantial influence on BMD changes postpartum.
引用
收藏
页码:184 / 189
页数:6
相关论文
共 39 条
[1]   VITAMIN-D-RECEPTOR GENE POLYMORPHISM, BONE MASS, BODY-SIZE, AND VITAMIN-D-RECEPTOR DENSITY [J].
BARGERLUX, MJ ;
HEANEY, RP ;
HAYES, J ;
DELUCA, HF ;
JOHNSON, ML ;
GONG, G .
CALCIFIED TISSUE INTERNATIONAL, 1995, 57 (02) :161-162
[2]   Fracture rate, pre- and postmenopausal bone mass and early and late postmenopausal bone loss are not associated with vitamin D receptor genotype in a high-endemic area of osteoporosis [J].
Berg, JP ;
Falch, JA ;
Haug, E .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 135 (01) :96-100
[3]  
Cooper GS, 1996, J BONE MINER RES, V11, P1841
[4]   BONE-MINERAL LOSS IN YOUNG-WOMEN WITH AMENORRHEA [J].
DAVIES, MC ;
HALL, ML ;
JACOBS, HS .
BRITISH MEDICAL JOURNAL, 1990, 301 (6755) :790-793
[5]  
EISMAN JA, 1995, J BONE MINER RES, V10, P1289
[6]   EVIDENCE OF ESTROGEN-RECEPTORS IN NORMAL HUMAN OSTEOBLAST-LIKE CELLS [J].
ERIKSEN, EF ;
COLVARD, DS ;
BERG, NJ ;
GRAHAM, ML ;
MANN, KG ;
SPELSBERG, TC ;
RIGGS, BL .
SCIENCE, 1988, 241 (4861) :84-86
[7]   VITAMIN-D-RECEPTOR-GENE POLYMORPHISMS AND CHANGE IN LUMBAR-SPINE BONE-MINERAL DENSITY [J].
FERRARI, S ;
RIZZOLI, R ;
CHEVALLEY, T ;
SLOSMAN, D ;
EISMAN, JA ;
BONJOUR, JP .
LANCET, 1995, 345 (8947) :423-424
[8]  
FLEET JC, 1995, J BONE MINER RES, V10, P985
[9]  
Garnero P, 1996, J BONE MINER RES, V11, P827
[10]   Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women [J].
Han, KO ;
Moon, IG ;
Kang, YS ;
Chung, HY ;
Min, HK ;
Han, IK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :991-995